Grownup sufferers obtaining VICTOZA in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin could possibly have an increased risk of hypoglycemia, which includes extreme hypoglycemia. In pediatric people a decade of age and more mature, the chance of hypoglycemia was increased with VICTOZA irrespective of insulin and/or metformi